Document is current
Any future updates will be listed below
-
Authors
Reitsam, Nic G.
Gäble, Alexander
Siebenhüter, Lisa
Schaller, Tina
Liesche-Starnecker, Friederike
Sipos, Eva
Dintner, Sebastian
Walz, Christoph
Babic, John
Trepel, Martin
Kircher, Malte
Fincke, Victoria E.
Johann, Pascal D.
Märkl, Bruno
Lapa, Constantin
Enke, Johanna S.
-
Funding
Funding for this research was provided by:
Universität Augsburg
- License Information
-
More Information
Article History
Received: 20 September 2025
Revised: 15 January 2026
Accepted: 16 January 2026
First Online: 27 January 2026
Declarations
:
: NGR received travel support from Bruker Spatial Biology, unrelated to this study. CL reports prior consulting activities for Blue Earth Diagnostics Ltd. and Novartis. JSE received travel support from Boston Scientific Medizintechnik GmbH, unrelated to this study. JB is an employee and shareholder at Ratio Therapeutics.
: Our study was approved by the responsible ethical committee of Ludwig-Maximilians-University of Munich (reference: project number 25-0654) and was performed in accordance with the Declaration of Helsinki. Written informed consent was obtained by the involved patients. For analyses involving publicly available transcriptomic datasets, we refer to the original publications for details regarding ethical approval and patient consent.
